Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implications for Management of PET Amyloid Classification Technology

NCT02778971 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT02778971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02778971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implications for Management of PET Amyloid Classification Technology
Lead sponsor
University of Utah
Phase
Observational
Overall status
Completed
Start date
June 30, 2016
Completion date
September 30, 2022
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, dementia, mild cognitive impairment